| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 07/03/2013 | EP2608791A1 A process for the preparation of imatinib base |
| 07/03/2013 | CN103189369A Pyridinones/pyrazinones, method of making, and method of use thereof |
| 07/03/2013 | CN103189363A Bisaryl-bonded aryltriazolones and use thereof |
| 07/03/2013 | CN103189361A Estrogen receptor modulators and use thereof |
| 07/03/2013 | CN103189053A Modified-release dosage forms of 5-ht2c agonists useful for weight management |
| 07/03/2013 | CN103183664A Naphthacridine derivate, preparation method and application thereof, and organic light-emitting device |
| 07/03/2013 | CN103183663A Preparation method for azelnidipine |
| 07/03/2013 | CN103183662A Pyridine ring-containing triazole derivative and preparation method thereof |
| 07/03/2013 | CN103183633A Condensed-cyclic compound and organic light emitting diode including same |
| 07/03/2013 | CN103183631A Novel isatin-5-sulfonamide derivative and application of same in preparation of medicines used for treating atypical pneumonia |
| 07/03/2013 | CN103183630A Substituted 4-aminocyclohexane derivatives |
| 07/03/2013 | CN102321072B Esomeprazole sodium hemihydrate |
| 07/03/2013 | CN102229601B Hexahydro-1-(5-isoquinoline sulfonyl)-1 (H)-1, 4- diazepine hydrochloride amorphous compound |
| 07/03/2013 | CN102060845B Fasudil crystal formation III as well as preparation method and application thereof |
| 07/03/2013 | CN101970418B Pyrazine derivative and its uses as protein kinase inhibitor |
| 07/03/2013 | CN101952259B Benzodiazepine compound and pharmaceutical composition |
| 07/03/2013 | CN101712675B Nitrogenous benzheterocycle derivate and application thereof in treating nervous and mental diseases |
| 07/03/2013 | CN101678007B Gonadotropin-releasing hormone receptor antagonists and its pharmaceutical application |
| 07/03/2013 | CN101613343B Caderofloxacin lactate crystals I and II and preparation method thereof |
| 07/02/2013 | US8476462 Sulfonyl cyanine dyes and derivatives |
| 07/02/2013 | US8476434 Protein kinase modulators and method of use |
| 07/02/2013 | US8476433 Agent exhibiting the properties of a cognitive function promoter (embodiments) |
| 07/02/2013 | US8476303 N-aminopyrrolylmethyltetrahydropyridines as anti-cancer agents |
| 07/02/2013 | US8476301 Pyrrolidin-3-ylacetic acid derivative |
| 07/02/2013 | US8476295 Bridged bicyclic RHO kinase inhibitor compounds, composition and use |
| 07/02/2013 | US8476293 Tricyclic compound and use thereof |
| 07/02/2013 | US8476289 Aza-bicyclohexyl substituted indolyl alkyl amino derivatives as novel inhibitors of histone deacetylace |
| 07/02/2013 | US8476286 Quinazoline derivatives which promote the release of parathyroid hormone |
| 07/02/2013 | US8476280 Compositions and methods for combating lower urinary tract dysfunctions with delta opioid receptor agonists |
| 07/02/2013 | US8476277 TRPV1 antagonists including dihydroxy substituent and uses thereof |
| 07/02/2013 | US8476257 Viral polymerase inhibitors |
| 07/02/2013 | US8476253 Amide derivative |
| 07/02/2013 | US8475819 Cyano anthranilamide insecticides |
| 07/02/2013 | CA2745829C Chemical process |
| 07/02/2013 | CA2737694C Novel cyclic benzimidazole derivatives useful anti-diabetic agents |
| 07/02/2013 | CA2731897C Diazepine and diazocane compounds as mc4 agonists |
| 07/02/2013 | CA2657469C Novel aminopyridine derivatives having aurora a selective inhibitory action |
| 07/02/2013 | CA2539766C Benzimidazole derivates: preparation and pharmaceutical applications |
| 07/02/2013 | CA2504582C Drug delivery device comprising a bilayered polymeric coating having an inhibitor of the mamalian target of rapamycin incorporated into the first polymeric coating layer |
| 07/02/2013 | CA2464094C Methods for ligand discovery |
| 06/27/2013 | WO2013096496A2 Compounds acting at multiple prostaglandin receptors giving a general anti-inflammatory response |
| 06/27/2013 | WO2013096194A1 Novel heterocyclic carboxamides as modulators of kinase activity |
| 06/27/2013 | WO2013096060A1 Compounds for inhibiting the interaction of bcl2 with binding partners |
| 06/27/2013 | WO2013096059A1 Compounds for inhibiting the interaction of bcl2 with binding partners |
| 06/27/2013 | WO2013096055A1 Compounds for inhibiting the interaction of bcl2 with binding partners |
| 06/27/2013 | WO2013096051A1 Compounds for inhibiting the interaction of bcl2 with binding partners |
| 06/27/2013 | WO2013096049A1 Compounds for inhibiting the interaction of bcl2 with binding partners |
| 06/27/2013 | WO2013095304A1 Processes for preparing indoles |
| 06/27/2013 | WO2013095275A1 Novel hepatitis c virus inhibitors |
| 06/27/2013 | WO2013094999A2 Organic compound, and organic electroluminescent device using same |
| 06/27/2013 | WO2013093850A1 Quinoline derivatives |
| 06/27/2013 | WO2013093842A1 Heterocyclyl derivatives and their use as prostaglandin d2 receptor modulators |
| 06/27/2013 | WO2013093484A1 Pyridinone and pyrimidinone derivatives as factor xia inhibitors |
| 06/27/2013 | WO2013092976A1 New piperidine derivatives, pharmaceutical compositions and uses thereof |
| 06/27/2013 | WO2013092893A1 Chemical compounds |
| 06/27/2013 | WO2013092868A1 N-thio-anthranilamide compounds and their use as pesticides |
| 06/27/2013 | WO2013092834A1 Herbicidal compounds |
| 06/27/2013 | WO2013092674A1 Heterocyclic compounds, medicaments containing said compounds, use thereof and processes for the preparation thereof |
| 06/27/2013 | WO2013092616A1 New aziridine compounds, pharmaceutical compositions and their use as acetyl-coa carboxylase inhibitors |
| 06/27/2013 | WO2013092512A1 Substituted benzylpyrazoles |
| 06/27/2013 | WO2013092460A1 Cyclic bisoxime microbicides |
| 06/27/2013 | WO2013091507A1 Heterocycle amido alkyloxy substituted quinazoline derivative and use thereof |
| 06/27/2013 | WO2013091011A1 Heterocyclic urea compounds |
| 06/27/2013 | WO2013064919A9 Quinazoline derivatives with hsp90 inhibitory activity |
| 06/27/2013 | US20130165483 Heteroaryls and uses thereof |
| 06/27/2013 | US20130165475 Deuterium-enriched heterocyclic compounds as kinase inhibitors |
| 06/27/2013 | US20130165472 Heteroaryls and uses thereof |
| 06/27/2013 | US20130165465 Crystalline Forms of 4-Methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamide |
| 06/27/2013 | US20130165464 Heteroaryls and uses thereof |
| 06/27/2013 | US20130165458 Quinazoline compounds as kinase inhibitors |
| 06/27/2013 | US20130165452 Substituted Heteroaryls |
| 06/27/2013 | US20130165449 Compounds and Method for Treatment of Cancer |
| 06/27/2013 | US20130165444 Piperidine Derivatives |
| 06/27/2013 | US20130165443 Biphenyl and phenyl-pyridine amides as p2x3 and p2x2/3 antagonists |
| 06/27/2013 | US20130165442 Modulators of ATP-Binding Cassette Transporters |
| 06/27/2013 | US20130165438 Prostaglandin d synthase inhibitory piperidine compounds |
| 06/27/2013 | US20130165431 Inhibitors of syk and jak protein kinases |
| 06/27/2013 | US20130165423 Substituted benzimidazoles and benzopyrazoles as ccr(4) antagonists |
| 06/27/2013 | US20130165422 Hexafluoroisopropyl carbamate derivatives, their preparation and their therapeutic application |
| 06/27/2013 | US20130165412 Cannabinoid receptor modulators |
| 06/27/2013 | US20130164259 1,4-substituted piperazine derivatives and methods of use thereof |
| 06/27/2013 | US20130164258 Antiviral Compounds Composed of Three Aligned Aryl Moieties to Treat Diseases such as Hepatitis C |
| 06/27/2013 | CA2858328A1 Heterocyclyl derivatives and their use as prostaglandin d2 receptor modulators |
| 06/27/2013 | CA2856448A1 Novel heterocyclic carboxamides as modulators of kinase activity |
| 06/26/2013 | EP2607362A1 Piperidine and piperazine carboxylates as FAAH inhibitors |
| 06/26/2013 | EP2607356A1 Triazole-substituted arylamide derivatives and their use as P2x3 and /or P2x2/3 purinergic receptor antagonists |
| 06/26/2013 | EP2606727A1 Compounds with nematicidal activity |
| 06/26/2013 | EP2606042A1 Disubstituted tetrahydofuranyl compounds as antagonists of the bradykinin b1 receptor |
| 06/26/2013 | EP2606038A1 Compounds for the treatment of hepatitis c |
| 06/26/2013 | EP2606036A1 New compounds |
| 06/26/2013 | EP2606035A1 Proces for the synthesis of substituted urea compounds |
| 06/26/2013 | EP2606034A1 Pyrimidine derivatives as fak inhibitors |
| 06/26/2013 | EP2606033A1 Substituted cyclic carboxamide and urea derivatives as ligands of the vanilloid receptor |
| 06/26/2013 | EP2606032A2 Composition and methods for treating glioblastoma |
| 06/26/2013 | EP2606031A2 Autotaxin inhibitors and uses thereof |
| 06/26/2013 | CN103180312A Heterocyclic compounds for treating or preventing disorders caused by reduced neurotransmission of serotonin, norephnephrine or dopamine |
| 06/26/2013 | CN103180311A Compounds useful for inhibiting CHK1 |
| 06/26/2013 | CN103180310A Hetero-bicyclic derivatives as hcv inhibitors |
| 06/26/2013 | CN103180309A Antagonist for mutated androgen receptor |
| 06/26/2013 | CN103180308A Novel method of preparing benzoimidazole derivatives |